Identification of HMMR as a prognostic biomarker for patients with lung adenocarcinoma via integrated bioinformatics analysis

BACKGROUND: Lung adenocarcinoma (LUAD) is the most prevalent tumor in lung carcinoma cases and threatens human life seriously worldwide. Here we attempt to identify a prognostic biomarker and potential therapeutic target for LUAD patients. METHODS: Differentially expressed genes (DEGs) shared by GSE...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhaodong, Fei, Hongtian, Lei, Siyu, Hao, Fengtong, Yang, Lijie, Li, Wanze, Zhang, Laney, Fei, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710063/
https://www.ncbi.nlm.nih.gov/pubmed/35036134
http://dx.doi.org/10.7717/peerj.12624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710063/
https://www.ncbi.nlm.nih.gov/pubmed/35036134
http://dx.doi.org/10.7717/peerj.12624

Ejemplares similares